209 related articles for article (PubMed ID: 17473197)
1. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.
Benlloch M; Ortega A; Ferrer P; Segarra R; Obrador E; Asensi M; Carretero J; Estrela JM
J Biol Chem; 2005 Feb; 280(8):6950-9. PubMed ID: 15561710
[TBL] [Abstract][Full Text] [Related]
3. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.
Benlloch M; Mena S; Ferrer P; Obrador E; Asensi M; Pellicer JA; Carretero J; Ortega A; Estrela JM
J Biol Chem; 2006 Jan; 281(1):69-79. PubMed ID: 16263711
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study on molecular mechanism of curcumine anti-mouse melanoma].
Gui F; Ma WF; Cai SH; Li XK; Tan Y; Zhou CL; Chen HY
Zhong Yao Cai; 2008 Nov; 31(11):1685-9. PubMed ID: 19260281
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
7. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature.
Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F
Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.
Ortega A; Ferrer P; Carretero J; Obrador E; Asensi M; Pellicer JA; Estrela JM
J Biol Chem; 2003 Oct; 278(41):39591-9. PubMed ID: 12881529
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.
Benimetskaya L; Ayyanar K; Kornblum N; Castanotto D; Rossi J; Wu S; Lai J; Brown BD; Popova N; Miller P; McMicken H; Chen Y; Stein CA
Clin Cancer Res; 2006 Aug; 12(16):4940-8. PubMed ID: 16914583
[TBL] [Abstract][Full Text] [Related]
10. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K
Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin induced apoptosis of B16-F10 melanoma cells through down-regulation of Bcl-2.
Jun HS; Park T; Lee CK; Kang MK; Park MS; Kang HI; Surh YJ; Kim OH
Food Chem Toxicol; 2007 May; 45(5):708-15. PubMed ID: 17306913
[TBL] [Abstract][Full Text] [Related]
12. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins.
Wolter KG; Verhaegen M; Fernández Y; Nikolovska-Coleska Z; Riblett M; de la Vega CM; Wang S; Soengas MS
Cell Death Differ; 2007 Sep; 14(9):1605-16. PubMed ID: 17541428
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
[TBL] [Abstract][Full Text] [Related]
16. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
[TBL] [Abstract][Full Text] [Related]
17. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis.
Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW
Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion.
Navarini AL; Chiaradia LD; Mascarello A; Fritzen M; Nunes RJ; Yunes RA; Creczynski-Pasa TB
Eur J Med Chem; 2009 Apr; 44(4):1630-7. PubMed ID: 19211173
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-based therapy for melanoma: pre-clinical studies.
Shurin MR; Kirkwood JM; Esche C
Forum (Genova); 2000; 10(3):204-26. PubMed ID: 11007930
[TBL] [Abstract][Full Text] [Related]
20. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
